Experimental AIDS vaccine: process bioreactors

Experimental AIDS vaccine: process bioreactors

G255/0030 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 27.3MB

Downloadable file size: 1.5MB

Price image Pricing

Please login to use the price calculator

This image is part of the feature Aids Vaccine



Caption: Process engineer monitors production-scale bioreactors containing insect cell cultures for the production of VaxSyn, an experimental AIDS vaccine. The vaccine is an engineered, recombinant form of the HIV protein gp160, which is a precursor to one of HIV's surface proteins. VaxSyn is genetically-engineered from the baculovirus (an insect virus), with insect cell cultures used in the scale-up process. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV- positive patients & as a potential vaccine against HIV infection.

Release details: Model release not available. Property release not required.

Keywords: aids, aids vaccine, aids vaccine production, bioengineered, bioengineering, bioreactor, biotechnology, drug, drugs, experimental, genetic, genetics, manufacture, production, vaccine, vaxsyn

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.